The Politics of the International Pricing of Prescription Drugs


Harrison analyzes how the U. S. research pharmaceutical industry, faced with domestic political opposition to the prices it charged for prescription drugs, chose to pursue its policy goal of greater appropriability of its intellectual property through the institutions of foreign economic policymaking.

Additional information


An unknown error has occurred. Please click the button below to reload the page. If the problem persists, please try again in a little while.